Private Equity

Updated:

Med Opportunity Partners

Med Opportunity Partners is a private equity firm focused on the healthcare industry. It has made one investment, in Vibrynt as part of their Series B on July...

Med Opportunity Partners logo

Med Opportunity Partners

Med Opportunity Partners is a private equity firm focused on the healthcare industry. It has made one investment, in Vibrynt as part of their Series B on July 11, 2008. The firm has one portfolio exit, Reliable Biopharmaceutical, which occurred on November 03, 2016.

General information

Firm type

Private Equity

Year founded

2006

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Greenwich

Corporate office

Greenwich, CT, United States

Sector focus

Healthcare Services

Frequently asked questions

What investment strategies does Med Opportunity Partners use?

The firm deploys capital through four distinct structures: buyouts, growth equity, PIPE (private investment in public equity) transactions, and recapitalizations. This range allows Med Opportunity Partners to provide both control capital to private companies and minority growth investments in situations where existing owners want to retain significant equity.

Is Med Opportunity Partners a single-family office?

No. Med Opportunity Partners is structured as a private equity asset manager, not a family office. It raises capital externally rather than managing a single family's wealth. The firm's ownership structure and limited partner base have not been publicly disclosed.

Which healthcare sub-sectors does Med Opportunity Partners target?

The firm focuses broadly on healthcare services, though its specific sub-sector preferences are not detailed publicly. Given the firm's lower-middle-market buyout and growth strategy, typical targets would include physician practice management, outsourced healthcare services, and ancillary provider platforms. No named portfolio companies have been disclosed to confirm specific verticals.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Greenwich Private Equity profiles